The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
Shandong Meditech Medical Technology is a manufacturer of onsite oxygen solutions for the healthcare market.
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
The company will reduce wastage substantially, increase productivity, enhance environmental consciousness, save energy, optimally use natural resources, and expand its market penetration
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
Subscribe To Our Newsletter & Stay Updated
